Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Metrics and Acquisition Modes for Fixation Stability as a Visual Function Biomarker.

Schönbach EM, Ibrahim MA, Kong X, Strauss RW, Muñoz B, Birch DG, Sunness JS, West SK, Scholl HPN.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO268-BIO276. doi: 10.1167/iovs.17-21710.

PMID:
28973313
2.

A SERIES OF FIVE PATIENTS WITH FOVEAL HYPOPLASIA DEMONSTRATING GOOD VISUAL ACUITY.

Kirchner ID, Waldman CW, Sunness JS.

Retin Cases Brief Rep. 2017 May 31. doi: 10.1097/ICB.0000000000000606. [Epub ahead of print]

PMID:
28574945
3.

Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.

Schönbach EM, Wolfson Y, Strauss RW, Ibrahim MA, Kong X, Muñoz B, Birch DG, Cideciyan AV, Hahn GA, Nittala M, Sunness JS, Sadda SR, West SK, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2017 Jul 1;135(7):696-703. doi: 10.1001/jamaophthalmol.2017.1162.

PMID:
28542693
4.

Visual Acuity Loss and Associated Risk Factors in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 2).

Kong X, Strauss RW, Michaelides M, Cideciyan AV, Sahel JA, Muñoz B, West S, Scholl HP; ProgStar Study Group.

Ophthalmology. 2016 Sep;123(9):1887-97. doi: 10.1016/j.ophtha.2016.05.027. Epub 2016 Jul 2.

PMID:
27378015
5.

Increased choroidal mast cells and their degranulation in age-related macular degeneration.

Bhutto IA, McLeod DS, Jing T, Sunness JS, Seddon JM, Lutty GA.

Br J Ophthalmol. 2016 May;100(5):720-6. doi: 10.1136/bjophthalmol-2015-308290. Epub 2016 Mar 1.

6.

MAPPING THE DENSE SCOTOMA AND ITS ENLARGEMENT IN STARGARDT DISEASE.

Bernstein A, Sunness JS, Applegate CA, Tegins EO.

Retina. 2016 Sep;36(9):1741-50. doi: 10.1097/IAE.0000000000001003.

7.

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.

Strauss RW, Ho A, Muñoz B, Cideciyan AV, Sahel JA, Sunness JS, Birch DG, Bernstein PS, Michaelides M, Traboulsi EI, Zrenner E, Sadda S, Ervin AM, West S, Scholl HP; Progression of Stargardt Disease Study Group.

Ophthalmology. 2016 Apr;123(4):817-28. doi: 10.1016/j.ophtha.2015.12.009. Epub 2016 Jan 16.

PMID:
26786511
8.

Stem cells in age-related macular degeneration and Stargardt's macular dystrophy.

Sunness JS.

Lancet. 2015 Jul 4;386(9988):29. doi: 10.1016/S0140-6736(15)61201-6. No abstract available.

PMID:
26169864
9.

Equating Visual Function Scales to Facilitate Reporting of Medicare Functional G-Code Severity/Complexity Modifiers for Low-Vision Patients.

Chan TL, Perlmutter MS, Andrews M, Sunness JS, Goldstein JE, Massof RW; Low Vision Research Network (LOVRNET) Study Group.

Arch Phys Med Rehabil. 2015 Oct;96(10):1859-65. doi: 10.1016/j.apmr.2015.06.013. Epub 2015 Jul 9.

10.

Clinically Meaningful Rehabilitation Outcomes of Low Vision Patients Served by Outpatient Clinical Centers.

Goldstein JE, Jackson ML, Fox SM, Deremeik JT, Massof RW; Low Vision Research Network Study Group.

JAMA Ophthalmol. 2015 Jul;133(7):762-9. doi: 10.1001/jamaophthalmol.2015.0693.

PMID:
25856370
11.

Dark adaptation abnormalities and recovery in acute thioridazine toxicity.

Scholz RT Sr, Sunness JS.

Retin Cases Brief Rep. 2014 Winter;8(1):45-9. doi: 10.1097/ICB.0000000000000000.

PMID:
25372207
12.

Characterizing functional complaints in patients seeking outpatient low-vision services in the United States.

Brown JC, Goldstein JE, Chan TL, Massof R, Ramulu P; Low Vision Research Network Study Group.

Ophthalmology. 2014 Aug;121(8):1655-62.e1. doi: 10.1016/j.ophtha.2014.02.030. Epub 2014 Apr 24.

PMID:
24768243
13.

Spontaneous improvement in visual acuity in age-related geographic atrophy of the macula.

Sunness JS.

JAMA Ophthalmol. 2014 Mar;132(3):356-7. doi: 10.1001/jamaophthalmol.2014.21. No abstract available.

PMID:
24626828
14.

Automated image alignment and segmentation to follow progression of geographic atrophy in age-related macular degeneration.

Ramsey DJ, Sunness JS, Malviya P, Applegate C, Hager GD, Handa JT.

Retina. 2014 Jul;34(7):1296-307. doi: 10.1097/IAE.0000000000000069.

PMID:
24398699
15.

Comparison of clinician-predicted to measured low vision outcomes.

Chan TL, Goldstein JE, Massof RW; Low Vision Research Network Study Group.

Optom Vis Sci. 2013 Aug;90(8):776-87. doi: 10.1097/OPX.0b013e31829d99d1.

16.

Responsiveness of the EQ-5D to the effects of low vision rehabilitation.

Malkin AG, Goldstein JE, Perlmutter MS, Massof RW; Low Vision Research Network Study Group.

Optom Vis Sci. 2013 Aug;90(8):799-805. doi: 10.1097/OPX.0000000000000005.

PMID:
23851303
17.

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, Davis MD; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2013 Aug;120(8):1604-11.e4. doi: 10.1016/j.ophtha.2013.01.021. Epub 2013 Apr 10.

18.

VA LOVIT II: a protocol to compare low vision rehabilitation and basic low vision.

Stelmack JA, Tang XC, Reda DJ, Stroupe KT, Rinne S, Massof RW; LOVIT II Study Group.

Ophthalmic Physiol Opt. 2012 Nov;32(6):461-71. doi: 10.1111/j.1475-1313.2012.00933.x. Epub 2012 Sep 7.

PMID:
22958237
19.

Baseline traits of low vision patients served by private outpatient clinical centers in the United States.

Goldstein JE, Massof RW, Deremeik JT, Braudway S, Jackson ML, Kehler KB, Primo SA, Sunness JS; Low Vision Research Network Study Group.

Arch Ophthalmol. 2012 Aug;130(8):1028-37.

PMID:
22893074
20.

Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial.

Paker AM, Sunness JS, Brereton NH, Speedie LJ, Albanna L, Dharmaraj S, Moser AB, Jones RO, Raymond GV.

Neurology. 2010 Aug 31;75(9):826-30. doi: 10.1212/WNL.0b013e3181f07061.

Supplemental Content

Loading ...
Support Center